(Q37367246)

20 August 2017

1 reference

title

Plasma lipoproteins: genetic influences and clinical implications (English)

1 reference

20 August 2017

1 reference

1

Robert A Hegele

0 references

publication date

13 January 2009

1 reference

20 August 2017

published in

Nature Reviews Genetics

1 reference

20 August 2017

volume

10

1 reference

20 August 2017

issue

2

1 reference

20 August 2017

page(s)

109-121

1 reference

Genetics of lipoprotein abnormalities associated with coronary artery disease susceptibility

20 August 2017

cites work

1 reference

Multiple Rare Alleles Contribute to Low Plasma Levels of HDL Cholesterol

31 March 2020

1 reference

A receptor-mediated pathway for cholesterol homeostasis

31 March 2020

1 reference

The role of cholesterol in Shh signaling and teratogen-induced holoprosencephaly

31 March 2020

1 reference

The role of orphan nuclear receptors in the regulation of cholesterol homeostasis

31 March 2020

1 reference

31 March 2020

1 reference

Translating molecular discoveries into new therapies for atherosclerosis

31 March 2020

1 reference

Promise of low-density lipoprotein-lowering therapy for primary and secondary prevention

31 March 2020

1 reference

New insights into the regulation of HDL metabolism and reverse cholesterol transport

31 March 2020

1 reference

Relationship of baseline serum cholesterol levels in 3 large cohorts of younger men to long-term coronary, cardiovascular, and all-cause mortality and to longevity

31 March 2020

1 reference

Familial lipoprotein disorders in patients with premature coronary artery disease

31 March 2020

1 reference

Applying apoB to the diagnosis and therapy of the atherogenic dyslipoproteinemias: a clinical diagnostic algorithm

31 March 2020

1 reference

The rationale for using apoA-I as a clinical marker of cardiovascular risk

31 March 2020

1 reference

Lipids, lipoproteins, and apolipoproteins as risk markers of myocardial infarction in 52 countries (the INTERHEART study): a case-control study

31 March 2020

1 reference

Role of the apolipoprotein B-apolipoprotein A-I ratio in cardiovascular risk assessment: a case-control analysis in EPIC-Norfolk

31 March 2020

1 reference

Nonfasting Triglycerides and Risk of Myocardial Infarction, Ischemic Heart Disease, and Death in Men and Women

31 March 2020

1 reference

Fasting compared with nonfasting triglycerides and risk of cardiovascular events in women

31 March 2020

1 reference

Cardiovascular disease mortality in familial forms of hypertriglyceridemia: A 20-year prospective study

31 March 2020

1 reference

Six new loci associated with blood low-density lipoprotein cholesterol, high-density lipoprotein cholesterol or triglycerides in humans

31 March 2020

1 reference

Genome-wide scan identifies variation in MLXIPL associated with plasma triglycerides

31 March 2020

1 reference

LDL-cholesterol concentrations: a genome-wide association study

31 March 2020

1 reference

Genome-wide association study identifies genes for biomarkers of cardiovascular disease: serum urate and dyslipidemia

31 March 2020

1 reference

Newly identified loci that influence lipid concentrations and risk of coronary artery disease

31 March 2020

1 reference

Loci influencing lipid levels and coronary heart disease risk in 16 European population cohorts

31 March 2020

1 reference

Common variants at 30 loci contribute to polygenic dyslipidemia

31 March 2020

1 reference

Genome-wide association analysis of metabolic traits in a birth cohort from a founder population

31 March 2020

1 reference

Multiple Genetic Determinants of Variation of Plasma Lipoproteins in Alberta Hutterites

31 March 2020

1 reference

Familial combined hyperlipidemia is associated with upstream transcription factor 1 (USF1).

31 March 2020

1 reference

WW-domain-containing oxidoreductase is associated with low plasma HDL-C levels

31 March 2020

1 reference

Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels

31 March 2020

1 reference

Association of apolipoprotein E genotypes with lipid levels and coronary risk

31 March 2020

1 reference

Association of cholesteryl ester transfer protein genotypes with CETP mass and activity, lipid levels, and coronary risk

31 March 2020

1 reference

Genetics of familial combined hyperlipidemia and risk of coronary heart disease

31 March 2020

1 reference

Genetic determinants of plasma lipoproteins

31 March 2020

1 reference

Monogenic hypercholesterolemia: new insights in pathogenesis and treatment

31 March 2020

1 reference

Molecular diagnosis of hypobetalipoproteinemia: an ENID review

31 March 2020

1 reference

Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency

31 March 2020

1 reference

Inherited disorders of HDL metabolism and atherosclerosis

31 March 2020

1 reference

Hypertriglyceridaemia due to genetic defects in lipoprotein lipase and apolipoprotein C-II

31 March 2020

1 reference

Mutations in LMF1 cause combined lipase deficiency and severe hypertriglyceridemia

31 March 2020

1 reference

GPIHBP1: an endothelial cell molecule important for the lipolytic processing of chylomicrons

31 March 2020

1 reference

Rare APOA5 mutations--clinical consequences, metabolic and functional effects: an ENID review

31 March 2020

1 reference

Intramuscular administration of AAV1-lipoprotein lipase S447X lowers triglycerides in lipoprotein lipase-deficient patients

31 March 2020

1 reference

Lipid disorders and mutations in the APOB gene.

31 March 2020

1 reference

Mutations in a Sar1 GTPase of COPII vesicles are associated with lipid absorption disorders

31 March 2020

1 reference

Medical sequencing at the extremes of human body mass

31 March 2020

1 reference

Most rare missense alleles are deleterious in humans: implications for complex disease and association studies

31 March 2020

1 reference

Low LDL cholesterol in individuals of African descent resulting from frequent nonsense mutations in PCSK9.

31 March 2020

1 reference

Multiple rare variants in NPC1L1 associated with reduced sterol absorption and plasma low-density lipoprotein levels

31 March 2020

1 reference

Functional characterization of genetic variants in NPC1L1 supports the sequencing extremes strategy to identify complex trait genes

31 March 2020

1 reference

Resequencing genomic DNA of patients with severe hypertriglyceridemia (MIM 144650)

31 March 2020

1 reference

Identification of genetic variants in endothelial lipase in persons with elevated high-density lipoprotein cholesterol

31 March 2020

1 reference

Angiopoietin-like protein 4 is a potent hyperlipidemia-inducing factor in mice and inhibitor of lipoprotein lipase

31 March 2020

1 reference

Population-based resequencing of ANGPTL4 uncovers variations that reduce triglycerides and increase HDL.

31 March 2020

1 reference

A second generation human haplotype map of over 3.1 million SNPs

31 March 2020

1 reference

A genome-wide association study for blood lipid phenotypes in the Framingham Heart Study

31 March 2020

1 reference

From Darwin's finches to canaries in the coal mine--mining the genome for new biology

31 March 2020

1 reference

Defining the spectrum of alleles that contribute to blood lipid concentrations in humans

31 March 2020

1 reference

What can the genome tell us about LDL cholesterol?

31 March 2020

1 reference

A treasure trove for lipoprotein biology

31 March 2020

1 reference

Carbohydrate response element binding protein, ChREBP, a transcription factor coupling hepatic glucose utilization and lipid synthesis

31 March 2020

1 reference

Global variation in copy number in the human genome

31 March 2020

1 reference

Genomic copy number variation and its potential role in lipoprotein and metabolic phenotypes

31 March 2020

1 reference

Glycosylphosphatidylinositol-anchored high-density lipoprotein-binding protein 1 plays a critical role in the lipolytic processing of chylomicrons

31 March 2020

1 reference

Normal binding of lipoprotein lipase, chylomicrons, and apo-AV to GPIHBP1 containing a G56R amino acid substitution

31 March 2020

1 reference

Apolipoprotein M is required for prebeta-HDL formation and cholesterol efflux to HDL and protects against atherosclerosis

31 March 2020

1 reference

ANGPTL3 decreases very low density lipoprotein triglyceride clearance by inhibition of lipoprotein lipase

31 March 2020

1 reference

Transgenic angiopoietin-like (angptl)4 overexpression and targeted disruption of angptl4 and angptl3: regulation of triglyceride metabolism

31 March 2020

1 reference

Accumulation of dietary cholesterol in sitosterolemia caused by mutations in adjacent ABC transporters

31 March 2020

1 reference

Disruption of cholesterol homeostasis by plant sterols

31 March 2020

1 reference

Niemann-Pick C1 Like 1 protein is critical for intestinal cholesterol absorption

31 March 2020

1 reference

Sequence variation in NPC1L1 and association with improved LDL-cholesterol lowering in response to ezetimibe treatment

31 March 2020

1 reference

Defective lipolysis and altered energy metabolism in mice lacking adipose triglyceride lipase

31 March 2020

1 reference

Adipose triglyceride lipase-mediated lipolysis of cellular fat stores is activated by CGI-58 and defective in Chanarin-Dorfman Syndrome

31 March 2020

1 reference

The role of lipin 1 in adipogenesis and lipid metabolism

31 March 2020

1 reference

Thematic review series: adipocyte biology. The perilipin family of structural lipid droplet proteins: stabilization of lipid droplets and control of lipolysis

31 March 2020

1 reference

Apolipoprotein E isoforms, serum cholesterol, and cancer.

31 March 2020

1 reference

Mendelian randomization: can genetic epidemiology help redress the failures of observational epidemiology?

31 March 2020

1 reference

Sequence variations in PCSK9, low LDL, and protection against coronary heart disease

31 March 2020

1 reference

Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins

31 March 2020

1 reference

Biomedicine. Lowering LDL--not only how low, but how long?

31 March 2020

1 reference

Association of loss-of-function mutations in the ABCA1 gene with high-density lipoprotein cholesterol levels and risk of ischemic heart disease

31 March 2020

1 reference

Levels of apolipoprotein M are not associated with the risk of coronary heart disease in two independent case-control studies

31 March 2020

1 reference

A thematic review series: systems biology approaches to metabolic and cardiovascular disorders

31 March 2020

1 reference

Discovery of expression QTLs using large-scale transcriptional profiling in human lymphocytes

31 March 2020

1 reference

Variations in DNA elucidate molecular networks that cause disease

31 March 2020

1 reference

On the allelic spectrum of human disease

31 March 2020

1 reference

Genome-wide association studies: theoretical and practical concerns

31 March 2020

1 reference

Polygenic determinants of severe hypertriglyceridemia

31 March 2020

1 reference

Evidence mandating earlier and more aggressive treatment of hypercholesterolemia

31 March 2020

1 reference

Polymorphisms associated with cholesterol and risk of cardiovascular events

31 March 2020

1 reference

Cardiovascular disease risk prediction using genetic information (gene scores): is it really informative?

31 March 2020

1 reference

Alternative splicing of 3-hydroxy-3-methylglutaryl coenzyme A reductase is associated with plasma low-density lipoprotein cholesterol response to simvastatin

31 March 2020

1 reference

Therapeutic RNAi targeting PCSK9 acutely lowers plasma cholesterol in rodents and LDL cholesterol in nonhuman primates

31 March 2020

1 reference

Antisense apolipoprotein B therapy: where do we stand?

31 March 2020

1 reference

The value of HDL genetics

31 March 2020

1 reference

APOA5 genetic variants are markers for classic hyperlipoproteinemia phenotypes and hypertriglyceridemia

31 March 2020

1 reference

An apolipoprotein A-V gene SNP is associated with marked hypertriglyceridemia among Asian-American patients

31 March 2020

1 reference

Pharmacogenetics of lipid diseases

31 March 2020

1 reference

A null mutation in human APOC3 confers a favorable plasma lipid profile and apparent cardioprotection

31 March 2020

1 reference

Identification of a gene, ABCG5, important in the regulation of dietary cholesterol absorption

31 March 2020

1 reference

12 December 2020

Naturally occurring mutations in mice affecting lipid transport and metabolism.

1 reference

12 December 2020

Dietary influences on serum lipids and lipoproteins

1 reference

12 December 2020

Genetic factors affecting blood lipoproteins: the candidate gene approach.

1 reference

12 December 2020

High density lipoproteins, reverse transport of cholesterol, and coronary artery disease. Insights from mutations.

1 reference

12 December 2020

Identifiers

DOI

10.1038/NRG2481

1 reference

20 August 2017

1 reference